Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment / Edition 5

Paperback (Print)
Buy New
Buy New from BN.com
$67.40
Buy Used
Buy Used from BN.com
$49.49
(Save 34%)
Item is in good condition but packaging may have signs of shelf wear/aging or torn packaging.
Condition: Used – Good details
Used and New from Other Sellers
Used and New from Other Sellers
from $2.28
Usually ships in 1-2 business days
(Save 96%)
Other sellers (Paperback)
  • All (11) from $2.28   
  • New (5) from $19.80   
  • Used (6) from $2.28   

Overview

Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment covers the entire spectrum of clinical drug therapy for adults, elderly adults, pregnant and nursing women, and children. Drugs are listed alphabetically, for quick navigation, and each drug entry includes name, molecular structure, dosing, pharmacological actions, indications and clinical applications, side effects and adverse/allergic reactions, and drug interactions. In the front are tables listing the chapters where each drug is discussed and the common disorders for which each is used. Color drug plates in the front help with rapid recognition of all major drugs.

Read More Show Less

Editorial Reviews

From The Critics
Reviewer: Michael Joel Schrift, D.O., M.A.(University of Illinois at Chicago College of Medicine)
Description: Although filled with information about the various classes of pharmacological agents, this update of a fairly popular handbook of psychopharmacology is more of an encyclopedia than a manual to assist practicing psychiatrists in the treatment of patients. It lacks treatment algorithms and discussions of the diagnostic validity vs. target symptom issues in treatment selection, and electroconvulsive therapy, arguably the most effective treatment in psychiatry, is only very indirectly mentioned (in the description of methohexital).
Purpose: The aim is to provide "to all those who work with and care for the mentally ill," an updated and revised book on the drug therapy used in the everyday practice of psychiatry.
Audience: The target audience, according to the editors, is psychiatrists, psychiatric residents, and medical students and nonpsychiatric physicians who prescribe psychotropic medications.
Features: The 35 chapters cover all the major classes of pharmacological agents used to treat patients with psychiatric disorders. Both on-label and off-label agents are discussed. Unfortunately, a discussion of when and where to use these agents is lacking. The information in the chapters is not referenced. The pictures of commonly used drugs and the index section, however, are helpful.
Assessment: "I did not learn anything new from this fifth edition. I cannot see the handbook as being useful for practicing psychiatrists, psychiatric residents, or nonpsychiatric physicians, although it possibly could serve as a reference for medical students. "
Read More Show Less

Product Details

  • ISBN-13: 9781609139681
  • Publisher: Lippincott Williams & Wilkins
  • Publication date: 8/1/2011
  • Edition description: Fifth
  • Edition number: 5
  • Pages: 320
  • Sales rank: 832,219
  • Product dimensions: 5.00 (w) x 7.90 (h) x 0.70 (d)

Table of Contents

 Contents
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
1. General Principles of Psychopharmacology . . . . . . . . . . . . . . . . . . . . . . . . . 1
2. α2-Adrenergic Receptor Agonists, α1-Adrenergic Receptor Antagonists:
Clonidine, Guanfacine, Minipress and Yohimbine. . . . . . . . . . . . . . . . . . . . 25
3. β-Adrenergic Receptor Antagonists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
4. Anticholinergics and Amantadine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
5. Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
6. Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
7. Barbiturates and Similarly Acting Drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
8. Benzodiazepines and Drugs Acting on Benzodiazepine Receptors . . . . . 68
9. Bupropion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
10. Buspirone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
11. Calcium Channel Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
12. Carbamazepine and Oxcarbazepine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
13. Cholinesterase Inhibitors and Memantine . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
14. Disulfiram and Acamprosate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
15. Dopamine Receptor Agonists and Precursors . . . . . . . . . . . . . . . . . . . . . . . . 113
16. Dopamine Receptor Antagonists (First Generation Antipsychotics) . . . . 118
17. Lamotrigine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
18. Lithium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
19. Melatonin Agonists: Ramelton and Melatonin . . . . . . . . . . . . . . . . . . . . . . . 157
20. Mirtazapine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
21. Monoamine Oxidase Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
22. Nefazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
23. Opioid Receptor Agonists: Methadone and Buprenorphine . . . . . . . . . . . 174
24. Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone . . 181
25. Phosphodiesterase-5 Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
26. Selective Serotonin–Norepinephrine Reuptake Inhibitors . . . . . . . . . . . . . 193
27. Selective Serotonin Reuptake Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
28. Serotonin–Dopamine Antagonists and Similarly Acting Drugs
(Second Generation or Atypical Antipsychotics) . . . . . . . . . . . . . . . . . . . . . 217
29. Sympathomimetics and Related Drugs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
30. Thyroid Hormones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
31. Trazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251
32. Tricyclics and Tetracyclics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255
33. Valproate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 266
34. Nutritional Supplements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 274
35. Intoxication and Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288
Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299
About the Authors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)